Inflammatory mediators as essential elements in bone remodeling

Calcified Tissue International

Volumn 73, Issue 2, 2003, Pages 97-100

  Goldring, S R ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Bone remodeling; Cytokines; Inflammation; Rheumatoid arthritis

Indexed keywords

AUTACOID; CYTOKINE; HORMONE; PARATHYROID HORMONE;

BIOMECHANICS; BONE MASS; BONE MATRIX; BONE REMODELING; BONE STRUCTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL TYPE; DISEASE ASSOCIATION; HOMEOSTASIS; HORMONE ACTION; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE MIGRATION; MECHANICAL STRESS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE REMODELING; CYTOKINES; HUMANS; OSTEOCLASTS;

EID: 0042838281     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-1049-y     Document Type: Review

References (34)

1. Burr DB (2002) Targeted and nontargeted remodeling. Bone 30:2-4
2. Parfitt AM (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30:5-7
3. Parfitt A (2001) Targeted and non-targeted bone remodeling: relationship to BMU origination and progression. Bone 30:585-587
4. Martin RB (2002) Is all cortical bone remodeling initiated by microdamage? Bone 30:8-13
5. Hofbauer LC, Khosla S, Dunstan CR et al. (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12
6. Suda T, Takahashi N, Udagawa N et al. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
7. Teitelbaum S (2000) Bone resorption by osteoclasts. Science 289:1504-1508
8. Goldring SR, Gravallese EM (2000) Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 12:195-199
9. Simonet WS, Lacey DL, Dunstan CR et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
10. Romas E, Gillespie M, Martin T (2002) Involvement of receptor activator of NF-κβ ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30:340-346
11. Kanzaki H, Chiba M, Shimizu Y et al. (2002) Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via PGE2 synthesis. J Bone Miner Res 17:210-220
12. Bateman T, Dunstan C, Ferguson V et al. (2000) Osteoprotegerin mitigates tail suspension-induced osteopenia. Bone 26:443-449
13. Kobayashi Y, Hashimoto F, Miyamoto H et al. (2000) Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression. J Bone Miner Res 15:1924-1934
14. Goldring SR, Gravallese EM (2000) Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2:33-37
15. Gravallese EM, Manning C, Tsay A et al. (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250-258
16. Haynes DR, Crotti TN, Loric M et al. (2001) Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 40:623-630
17. Kuratani T, Nagata K, Kukita T et al. (1998) Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol 13:751-759
18. Romas E, Bakharevski O, Hards DK et al. (2000) Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 43:821-826
19. Suzuki Y, Nishikaku F, Nakatuka M et al. (1998) Osteoclast-like cells in murine collagen-induced arthritis. J Rheumatol 25:1154-1160
20. Fujikawa Y, Shingu M, Torisu T et al. (1996) Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 35:213-217
21. Chang JS, Quinn JM, Demaziere A et al. (1992) Bone resorption by cells isolated from rheumatoid synovium. Ann Rheum Dis 51:223-1229
22. Suzuki Y, Tsutsumi Y, Nakagawa M et al. (2001) Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium. Rheumatology (Oxford) 40:673-682
23. Pettit A, Hong J, von Stechow D et al. (2001) TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159:1689-1699
24. Redlich K, Hayer S, Maier A et al. (2002) Tumor necrosis factor-α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46:785-792
25. Kong YY, Feige U, Sarosi I et al. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309
26. Horwood NJ, Kartsogiannis V, Quinn JMW et al. (1999) Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144-150
27. Takayanagi H, Iizuka H, Juji T et al. (2000) Involvement of receptor activator of nuclear factor kappa-β ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259-269
28. Tsuboi M, Kawakami A, Nakashima T et al. (1999) Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 134:190-191
29. Chen S, Guttridge D, Tang E et al. (2001) Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaβ-independent bone morphogenetic protein/Smad signaling. J Biol Chem 276:39259-39263
30. Shimizu S, Shiozawa S, Shiozawa K et al. (1985) Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 28:25-31
31. Bromley M, Woolley DE (1984) Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 27:857-863
32. Goldring SR (1996) Osteoporosis and rheumatic diseases. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd ed. Lippincott-Raven, Philadelphia, pp 299-301
33. Goldring SR, Polisson RP (1998) Bone disease in rheumatological disorders. In: Avioli L, Krane SM (eds) Metabolic bone disease, 2nd ed. Academic Press, San Diego, pp 621-635
34. Saag K, Rochelle K, Caldwell J et al. (1994) Low-dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96:115-123